Viaxxel Biotech GmbHLiquidated

Master Data

Basic information of the organization

Registry

Registered

10/26/2000

IndustryClassified using Destatis WZ standard, derived from commercial register and web data by Fusionbase AI.

Research and experimental development on biotechnologyResearch and experimental development on biotechnologyWZ 72.10.1PrimaryWholesale of pharmaceutical goodsWholesale of pharmaceutical goodsWZ 46.46.1Manufacture of basic pharmaceutical productsManufacture of basic pharmaceutical productsWZ 21.10.0

Purpose

Gegenstand des Unternehmens ist die Erforschung, Entwicklung, Produktion und der Vertrieb von Arzneimitteln, Diagnostika, medizinisch-technischen Produkten und anderen Therapeutika.

History

Changes published in the official company registry

No events found for this filter

Management

Legal representatives of the organization

Name	Role	Entry Date
Hans Dr. Melbinger since 11/10/2004	Liquidator	11/10/2004

Beneficial Owners

Natural persons who ultimately own or control the company, resolved through the shareholder chain

Identified persons (5)

Name	Ownership
Dr. Hans Melbinger	40.00%
J**** H***	24.00%
Prof. Dr. A****** S**********	12.00%

Shareholders

Company ownership and partner structure

5 shareholders

GmbH structure

4 of 5 shown

Hans Melbinger

Bubenreuth

€32,000

40.00%

J****** H*****

—

€19,200

24.00%

A******** S************

—

€9,600

12.00%

A****** H*****

—

€9,600

12.00%

News & Media Coverage

Insolvency Notices

Real-time check for insolvency notices from register courts

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Real-time document download from the commercial register

Shareholder List

Current Print (Aktueller Abdruck)

Chronological Print (Chronologischer Abdruck)